logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
V

Vivian Lanius

bristol-myers squibb

3H-index
9Paper Count
56Citation Count
Published Papers 4
Publication Date
logo
Rejoinder - Statistical Methodology Groups in the Pharmaceutical Industry#
errStatistics in Biopharmaceutical Research
IF1.3
err2026-04-30
err0
PREAI
errDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
errShare
errSave
Statistical Methodology Groups in the Pharmaceutical Industry#
errStatistics in Biopharmaceutical Research
IF1.3
err2026-04-09
err1
PREAI
errDevenport, Jenny; Mielke, Tobias; Akacha, Mouna; Rufibach, Kaspar; Ocampo, Alex; Lanius, Vivian; Vandemeulebroecke, Marc; Hougaard, Philip; Collin, Pierre; Wright, David; Hummel, Jurgen; Kunz, Cornelia Ursula; Krams, Mike
errShare
errSave
Applying the estimand framework to clinical pharmacology trials with a case study in bioequivalence
errBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
IF3
err2024-11-25
err0
errOAAI
errLynggaard, Helle; Mckendrick, Sue; Baird, Mark; Kerwash, Essam; Lanius, Vivian; Lasch, Florian; Wright, David
errShare
errSave
Why estimands are needed to define treatment effects in clinical trials
errBMC MEDICINE
IF8.3
err2023-07-27
err10
errOAAI
errKeene, Oliver N.; Lynggaard, Helle; Englert, Stefan; Lanius, Vivian; Wright, David
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Philip Hougaard
H-index: 53 · Papers: 159
K
Kaspar Rufibach
H-index: 44 · Papers: 182
M
Mark E. Baird
H-index: 39 · Papers: 156
O
Oliver N. Keene
H-index: 38 · Papers: 119
D
David Wright
H-index: 24 · Papers: 127
View more